KAT2B and cancer: Microarray analyses revealed reduced PCAF mRNA levels in several types of cancer, including colon, lung, and bladder [236], which was supported by immunohistochemical data showing decreased PCAF protein expression in human intestinal type gastric cancer and colorectal tumors [236,237].